Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sandor Lueff"'
Autor:
Sarolta Nahajevszky, Hajnalka Andrikovics, Arpad Batai, Emma Adam, Andras Bors, Judit Csomor, Laszlo Gopcsa, Magdalena Koszarska, Andras Kozma, Nora Lovas, Sandor Lueff, Zoltan Matrai, Nora Meggyesi, Janos Sinko, Andrea Sipos, Andrea Varkonyi, Sandor Fekete, Attila Tordai, Tamas Masszi
Publikováno v:
Haematologica, Vol 96, Iss 11 (2011)
Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years. A germline Janus kinase 2 haplotype designated as the 46/1 haplotype has bee
Externí odkaz:
https://doaj.org/article/ac88012fc4f3488ab632138d40c784fc
Publikováno v:
Future oncology (London, England). 18(7)
Bruton’s tyrosine kinase inhibitors have changed the treatment landscape for chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and lymphoplasmacytic lymphoma dramatically. In 2019, acalabrutinib was approved by the US FDA for the treat
Autor:
Viktoria Gyorine Korom, Andrea Liposits, Miklos Egyed, Sandor Lueff, Anett Pavlovics, Ádám Kellner
Publikováno v:
Polish Archives of Internal Medicine.
Autor:
Andrea Sipos, Sandor Lueff, Árpád Bátai, Anikó Barta, András Bors, András Kozma, Péter Reményi, Emma Ádám, Attila Tordai, Hajnalka Andrikovics, Gabriella Halm, György Ujj, Sarolta Nahajevszky, Nóra Meggyesi, Sandor Fekete, Tamas Masszi
Publikováno v:
Acta Haematologica. 127:34-42
Background: Additional chromosome abnormalities (ACAs), mutations of the BCR-ABL tyrosine kinase domain (TKD) and BCR-ABL splice variants may cause resistance to first- and second-generation tyrosine kinase inhibitors (TKIs) in chronic myelogenous le
Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy
Autor:
Gusztav Font, Tamas Masszi, Marienn Réti, Marton Vertesaljai, Sandor Lueff, Eszter D. Juhasz, Géza Fontos, Laszlo Ablonczy, Tamás Simor, Gyorgy Andreka, Gergely Szantho, Péter Andréka, Mark S. Turner, Zsolt Piroth
Publikováno v:
Heart Failure Reviews. 13:227-244
In the past few years, the dogma that the heart is a terminally differentiated organ has been challenged. Evidence from preclinical investigations emerged that there are cells, even in the heart itself, that may be able to restore impaired cardiac fu
Autor:
Janos Sinko, Attila Tordai, Magdalena Koszarska, Andrea Sipos, Árpád Bátai, Tamás Masszi, Sarolta Nahajevszky, Nóra Meggyesi, László Gopcsa, Judit Csomor, Andrea Várkonyi, Zoltán Mátrai, Sándor Fekete, András Bors, Sandor Lueff, Nóra Lovas, Emma Ádám, Hajnalka Andrikovics, András Kozma
Publikováno v:
Haematologica. 96(11)
Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years. A germline Janus kinase 2 haplotype designated as the 46/1 haplotype has bee
Autor:
Attila Tordai, Miklos Egyed, Magdalena Koszarska, Z. Matrai, N. Lovas, Nóra Meggyesi, Andrea Sipos, Gábor Mikala, Sandor Lueff, Gabriella Halm, A. Kozma, S. Fekete, E. Adam, Tamás Masszi, Hajnalka Andrikovics, R Rasonyi, Judit Várkonyi, A. Bors, Sarolta Nahajevszky, Judit Csomor
Publikováno v:
Leukemia. 24(10)
Somatic gain-of-function mutation of the Janus kinase (JAK2) gene (NM_004972.2: c.1849G>T transversion resulting in V617F) has been identified in BCR–ABL-negative chronic myeloproliferative neoplasms (MPNs) (in >95% of polycythaemia vera (PV), and
Autor:
Judit Várkonyi, Attila Tóth, Sandor Lueff, Zoltán Pozsonyi, István Karádi, Antonello Pietrangelo, Nikolette Szücs
Publikováno v:
Università degli studi di Modena e Reggio Emilia-IRIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c736404d5ddb0e116de4df89fe169fdc
https://hdl.handle.net/11380/640837
https://hdl.handle.net/11380/640837
Autor:
Zoltán Mátrai, Andrea Sipos, Attila Tordai, Sandor Lueff, Gabriella Halm, Anikó Szilvási, Tamas Masszi, Viktória Király, Gabor Mikala, Zoltán Csukly, Sarolta Nahajevszky, Júlia Tamáska, Nóra Meggyesi, Hajnalka Andrikovics, Nóra Lovas
Publikováno v:
Orvosi hetilap. 148(5)
The Val617Phe point mutation of Janus kinase 2 gene is believed to participate in the pathogenesis of myeloproliferative syndrome characterised by the clonal alteration of hematopoetic stem cells. According to current results, the frequency of Val617
Autor:
E. Adam, P. Reményi, Z. Csukly, N. Lovas, A. Batai, Gabriella Halm, T. Masszi, B. Kapás, Nóra Meggyesi, Attila Tordai, Sandor Lueff, A. Kozma, H. Andrikovics, Sarolta Nahajevszky
Publikováno v:
Blood Reviews. 21:S78-S79